Skip to Main Content

Author Details

Melissa A Troester
1996
246
41
PMIDPaper TitleJournal TitlePublished Year
38070094Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer.Breast Cancer Res Treat2024
37095707Identifying patient profiles of disparate care in resectable pancreas cancer using latent class analysis.2023
36103105Job loss, return to work, and multidimensional well-being after breast cancer treatment in working-age Black and White women.Journal of Cancer Survivorship2023
36260525Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes.Clin Cancer Res2023
36394182Healthcare system engagement and algorithm-identified cancer incidence following initiation of a new medication.Pharmacoepidemiol Drug Saf2023
37952058Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study.NPJ Breast Cancer2023
37963365From Race to Racism and Disparities to Equity: An Actionable Biopsychosocial Approach to Breast Cancer Outcomes.2023
36974548Discrimination between Precancerous Gastric Lesions and Gastritis Using a Gastric Cancer Risk Stratification Model.2023
36968228Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population.Cancer Res Commun2023
37205649A complex systems model of breast cancer etiology: The Paradigm II Model.PLoS One2023
36892725Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.Breast Cancer Res Treat2023
36824750Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.Res Sq2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37438515Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study.2023
37308906Influence of alcohol consumption and alcohol metabolism variants on breast cancer risk among Black women: results from the AMBER consortium.2023
36798154Diffsig: Associating Risk Factors With Mutational Signatures.bioRxiv2023
36993425Molecular Features of Androgen-Receptor Low, Estrogen Receptor-Negative Breast Cancers in the Carolina Breast Cancer Study.2023
35286522Differences in somatic TP53 mutation type in breast tumors by race and receptor status.Breast Cancer Res Treat2022
36303815A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women.Cancer Res Commun2022
35701440Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases.NPJ Breast Cancer2022
35583138Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer.JNCI Cancer Spectr2022
36223240Burden of lymphedema in long-term breast cancer survivors by race and age.Cancer2022
35437570The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.Cancer Epidemiol Biomarkers Prev2022
36077818DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma.Cancers (Basel)2022
35690277Toward a digital analysis of environmental impacts on rodent mammary gland density during critical developmental windows.Reproductive Toxicology2022
35565277Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression.Cancers (Basel)2022
35554533Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.Hum Mol Genet2022
35418701Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.Sci Rep2022
36328784Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.Br J Sports Med2022
36129803RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer.Cancer Epidemiol Biomarkers Prev2022
36321309Race and Ancestry in Immune Response to Breast Cancer.Cancer Discov2022
35723569Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.J Natl Cancer Inst2022
36497482Do Patient-Reported Upper-Body Symptoms Predict Breast Cancer-Related Lymphoedema: Results from a Population-Based, Longitudinal Breast Cancer Cohort Study.2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
34795033APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.Cancer Immunol Res2022
34737209TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study.Cancer Epidemiol Biomarkers Prev2022
35275284The association between meat and fish intake by preparation methods and breast cancer in the Carolina Breast Cancer Study (CBCS).Breast Cancer Research and Treatment2022
35034243Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression.Breast Cancer Res Treat2022
35218811Quantitative analysis of breast cancer tissue composition and associations with tumor subtype.Human Pathology2022
34711612Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer.Cancer Res2022
35131882A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and Pepsinogen.Cancer Epidemiology Biomarkers and Prevention2022
35006482Breast cancer treatment patterns by age and time since last pregnancy in the Carolina Breast Cancer Study Phase III.Breast Cancer Res Treat2022
35108027Linking Structural Racism and Discrimination and Breast Cancer Outcomes: A Social Genomics Approach.J Clin Oncol2022
34810211Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013.Cancer Epidemiol Biomarkers Prev2022
34417337Lung and extrathoracic cancer incidence among underground uranium miners exposed to radon progeny in the Pſíbram region of the Czech Republic: a case-cohort study.Occupational and Environmental Medicine2022
34714340Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.JAMA Netw Open2021
35432688JOINT AND INDIVIDUAL ANALYSIS OF BREAST CANCER HISTOLOGIC IMAGES AND GENOMIC COVARIATES.Ann Appl Stat2021
32359158Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.J Natl Cancer Inst2021
33544892Race, ethnicity and risk of second primary contralateral breast cancer in the United States.International Journal of Cancer2021
34234117Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.Nat Commun2021
  • 1 - 50 of 246

Recommended Authors

Collaborators

Co-authored papers 86
Co-authored papers 47
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 31
Roswell Park Comprehensive Cancer Center
Co-authored papers 30
University of Southern California
Co-authored papers 26
National Cancer Institute
Co-authored papers 26
Co-authored papers 24
Co-authored papers 19
Co-authored papers 18
Co-authored papers 17
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 17
Co-authored papers 17
University of Cambridge
Co-authored papers 17
University of North Carolina at Chapel Hill
Co-authored papers 17
Mayo Clinic
Co-authored papers 17
Co-authored papers 17
The Usher Institute, The University of Edinburgh
Co-authored papers 16
Co-authored papers 16
National Cancer Institute, National Institutes of Health
Co-authored papers 15
German Cancer Research Center (DKFZ)
Co-authored papers 14
Mayo Clinic
Co-authored papers 14
Co-authored papers 14
Co-authored papers 14
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 13
German Cancer Research Center (DKFZ)
Co-authored papers 13
Co-authored papers 13
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12
University of California irvine
Co-authored papers 12